<DOC>
	<DOCNO>NCT00062582</DOCNO>
	<brief_summary>The aim study compare effect roflumilast placebo lung function patient COPD .</brief_summary>
	<brief_title>Effect Roflumilast Pulmonary Function Respiratory Symptoms Patients With Chronic Obstructive Pulmonary Disease ( COPD ) ( BY217/M2-110 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<criteria>Main Clinical diagnosis COPD ( Chronic Obstructive Pulmonary Disease ) Currently stable COPD change COPD treatment prior 4 week Main Clinical diagnosis asthma Poorly control COPD Regular need daily oxygen therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Roflumilast</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
</DOC>